View drug registration information details.
Items | Registration information |
ID | 2185 |
No | 2185 |
Brand Name | EZIUM |
Ingredients | ESOMEPRAZOLE MAGNESIUM 22.5 % PELLETS EQ.TO ESOMEPRAZOLE 40 MG |
Dosage Form | CAPSULE |
Primary Packaging | ALU-BLISTER |
Storage | |
Shelf Life | 3 YEARS |
Pack Size | 2 X 7 CAPSULES/BOX |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | GASTROESOPHAGEAL REFLUX DISEASE, TREATMENT OF EROSIVE REFLUX ESOPHAGITIS, LONG TERM MANAGEMENT OF PATIENTS WITH HEALED ESOPHAGITIS TO PREVENT RELAPSE, SYMPTOMATIC TREATMENT OF GERD WITHOUT ESOPHAGITIS. AS A TRIPLE THERAPY(ESOMEPRAZOLE + AMOXICILLIN +CLARITHROMYCIN) FOR THE ERADICATION OF HELICOBACTER PYLORI, HEALING OF DUODENAL ASSOCIATED WITH H.PYLORI INFECTION, PREVENTION OF RELAPSE OF PEPTIC ULCERS IN PATIENTS WITH H.PYLORI, ASSOCIATED ULCERS |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | OPAQUE, DARK PURPLE, HARD GELATIN CAPSULES, CONTAINING OFF WHITE ENTERIC COATED PELLETS,SIZE NO 3, EZIUM 40 PRINTED ON BODY |
Note | |
License Owner | POUNSAB PHARMA CO.,LTD |
Manufacturer | THE SEARLE COMPANY LIMITED |
Country | PAKISTAN |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 02 I 4902/20 |
FDD Registration Date | 19-Apr-2023 |
Expiry Date | 18-Apr-2026 |
Back to drug list
|